Minim Invasive Neurosurg 2011; 54(05/06): 290
DOI: 10.1055/s-0031-1297988
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Letter to the Editor: Percutaneous Chemical Dorsal ­Sympathectomy for Hyperhidrosis

Authors

  • A.E. P. Cameron

    1   Department of Surgery, The Ipswich ­Hospital, Ipswich, UK
  • C. Connery

    2   Department of Surgery, St Luke’s-­Roosevelt Hospital Center, New York, NY, USA
  • J.R. M. De Campos

    3   Department of Thoracic Surgery, University of Sao Paolo, Sao Paolo, Brazil
  • M. Hashmonai

    4   Faculty of Medicine, Technion-Israel Institue of Technology, Haifa, Israel
  • P. B. Licht

    5   Department of Cardiothoracic Surgery, Odense University ­Hospital, Odense, Denmark
  • C. H. Schick

    6   German Hyperhidrosiscenter, Surgery Isar Clinic, Munich, Germany
  • G. Bischof

    7   Department of Surgery, St Josef ­Hospital, Surgery, Vienna, Austria
  • on behalf of the International Society of Symapathetic Surgery
Further Information

Publication History

Publication Date:
25 January 2012 (online)

Sir,

We read with interest the article of Dr. Ebrahim [1]. The use of sympathetic block to treat palmar hyperhidrosis was tested in the past. 2 series were published [2] [3]. The group of Adler noticed a 10% recurrence at 4 months. A subsequent follow-up of their cases [4] revealed 40% recurrences and the method of treating palmar hyperhidrosis by phenol blocks was abandoned by this group of authors. In another study of chemical lumbar blocks performed to treat plantar hyperhidrosis [5], recurrence occurred in 89.9% of patients at 6–18 months. Taking into consideration these medium-term results, we wonder at the overall merits of chemical blocks over surgery for the treatment of primary hyperhidrosis. Dr. Ebrahim has a 1-year follow-up of his patients and already noticed 10% recurrences. We urge him to follow his patients for another year and publish at that time his results.